204 related articles for article (PubMed ID: 18809758)
1. Down-regulation of hepcidin in porphyria cutanea tarda.
Ajioka RS; Phillips JD; Weiss RB; Dunn DM; Smit MW; Proll SC; Katze MG; Kushner JP
Blood; 2008 Dec; 112(12):4723-8. PubMed ID: 18809758
[TBL] [Abstract][Full Text] [Related]
2. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
[TBL] [Abstract][Full Text] [Related]
3. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
5. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene.
Altès A; Bach V; Ruiz A; Esteve A; Felez J; Remacha AF; Sardà MP; Baiget M
Ann Hematol; 2009 Oct; 88(10):951-5. PubMed ID: 19214511
[TBL] [Abstract][Full Text] [Related]
6. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
[TBL] [Abstract][Full Text] [Related]
7. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
[TBL] [Abstract][Full Text] [Related]
8. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
Young LC
Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029
[TBL] [Abstract][Full Text] [Related]
9. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
10. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH
Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.
Kratka K; Dostalikova-Cimburova M; Michalikova H; Stransky J; Vranova J; Horak J
Br J Dermatol; 2008 Sep; 159(3):585-90. PubMed ID: 18565178
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
Frank J; Poblete-Gutiérrez P; Weiskirchen R; Gressner O; Merk HF; Lammert F
Physiol Res; 2006; 55 Suppl 2():S75-83. PubMed ID: 17298224
[TBL] [Abstract][Full Text] [Related]
13. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
Wolff CF; Armas RM; Frank J; Poblete PG
Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
[TBL] [Abstract][Full Text] [Related]
14. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
15. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
[TBL] [Abstract][Full Text] [Related]
16. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
[TBL] [Abstract][Full Text] [Related]
17. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
19. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
Stölzel U; Köstler E; Schuppan D; Richter M; Wollina U; Doss MO; Wittekind C; Tannapfel A
Arch Dermatol; 2003 Mar; 139(3):309-13. PubMed ID: 12622622
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
